Arsenic and platelet count decreased Patient Reports February 12, 2012

Arsenic Side Effects Report #5926589-9
Arsenic side effect was reported by a Health Professional from ITALY on Oct 01, 2008. Male patient, 75 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, cardiac failure, electrocardiogram repolarisation abnormality, hypoxia, pco2 decreased, platelet count decreased, sinus tachycardia. Arsenic dosage: 25.2 MG CYCLE 1 INTRAVENOUS DRIP. During the same period patient was treated with CLORFENAMINA MALEATO, IRBESARTAN, METFORMIN HYDROCHLORIDE, LENOGASTRIM, ASCORBIC ACID, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5853385-3
Arsenic side effect was reported by a Physician from ITALY on Jan 23, 2008. Male patient, 74 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, cardiac failure, dyspnoea, pco2 decreased, platelet count decreased, po2 decreased. Arsenic dosage: 25.2 MG CYCLE 1 INTRAVENOUS DRIP. During the same period patient was treated with CLORFENAMINA MALEATO, IRBESARTAN, METFORMIN, LENOGASTRIM. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5994520-6
Arsenic side effect was reported by a Physician from ITALY on Dec 04, 2008. Male patient, 74 years of age, weighting 185.2 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, blood lactate dehydrogenase increased, cardiac failure, dyspnoea, pco2 decreased, platelet count decreased, po2 decreased, sinus tachycardia. Arsenic dosage: 25.2 MG CYCLE 1 INTRAVENOUS DRIP. During the same period patient was treated with CLORFENAMINA MALEATO, IRBESARTAN, METFORMIN, LENOGRASTIM, ASCORBIC ACID, POTASSIUM CHLORIDE. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5907484-8
Arsenic side effect was reported by a Physician from ITALY on Sept 22, 2008. Male patient, 67 years of age, weighting 136.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: bronchopneumonia, haemoglobin decreased, neutrophil percentage decreased, platelet count decreased, respiratory depression, white blood cell count decreased. Arsenic dosage: 15 MG TWO TIMES PER WEEK (3 CYCLES) INTRAVENOUS DRIP. During the same period patient was treated with ARSENIC TRIOXIDE, ZELITREX, POTASSIUM CHLORIDE, MAG. Patient was hospitalized. Patient recovered.


Arsenic Side Effects Report #5926642-X
Arsenic side effect was reported by a Health Professional from ITALY on Oct 01, 2008. Male patient, 67 years of age, weighting 136.7 lb, was diagnosed with myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: bronchopneumonia, chlamydia identification test positive, haemoglobin decreased, neutrophil percentage decreased, platelet count decreased, pneumocystis jiroveci infection, respiratory depression, sputum culture positive, white blood cell count decreased. Arsenic dosage: 15 MG TWO TIMES PER WEEK (3 CYCLES) INTRAVENOUS DRIP. During the same period patient was treated with ARSENIC TRIOXIDE, ZELITREX, POTASSIUM CHLORIDE, MAG. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #4687430-8
Arsenic side effect was reported by a Health Professional from on June 09, 2005. Female patient, 53 years of age, weighting 196.0 lb, was diagnosed with multiple myeloma  and was treated with Arsenic. After drug was administered, patient experienced the following side effects: catheter related infection, chills, diarrhoea, dizziness , haemoglobin decreased, herpes simplex , platelet count decreased, pyrexia, staphylococcal infection . Arsenic dosage: 22 MG QD X 5 DAYS INTRAVENOU. During the same period patient was treated with LEVOTHYROXINE, SERTRALINE, ESTROGEN, FEXOFENADINE, ACETAMINOPHEN, PROPANOLOL, AMBIEN. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #4940793-8
Arsenic side effect was reported by a Physician from JAPAN on Feb 21, 2006. Male patient, 67 years of age, was diagnosed with acute promyelocytic leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, disseminated intravascular coagulation, gamma-glutamyltransferase increased, hepatic function abnormal, platelet count decreased, white blood cell count decreased. Arsenic dosage: 9.3 MG QD INTRAVENOUS DRIP. During the same period patient was treated with NAFAMOSTAT MESILATE. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #4918805-7
Arsenic side effect was reported by a Physician from UNITED STATES on Feb 03, 2006. Male patient, 76 years of age, weighting 167.6 lb, was diagnosed with acute myeloid leukaemia, myelodysplastic syndrome and was treated with Arsenic. After drug was administered, patient experienced the following side effects: blood bicarbonate decreased, cryptogenic organizing pneumonia, febrile neutropenia, haemoglobin decreased, hypotension, lung infiltration, lung neoplasm, platelet count decreased, white blood cell count decreased. Arsenic dosage: 20 MG Q72HR INTRAVENOUS DRIP. During the same period patient was treated with ARSENIC TRIOXIDE, MYLOTARG, DIFLUCAN, LOTREL, ATENOLOL, SYNTHROID, PRILOSEC. Patient was hospitalized. Patient recovered.

Arsenic Side Effects Report #5614444-3
Arsenic side effect was reported by a Physician from UNITED KINGDOM on Jan 15, 2008. Female patient, 71 years of age, was diagnosed with acute myeloid leukaemia and was treated with Arsenic. After drug was administered, patient experienced the following side effects: brain herniation, haemoglobin decreased, hydrocephalus , platelet count decreased, subdural haemorrhage, white blood cell count increased. Arsenic dosage: unknown. During the same period patient was treated with CYTARABINE. Patient recovered.